Disseminated Lyme borreliosis (early [Stage II] and late [Stage III])

Active Ingredient: Ceftriaxone

Indication for Ceftriaxone

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

For this indication, competent medicine agencies globally authorize below treatments:

50-80 mg/kg once daily

Route of admnistration

Intravenous

Defined daily dose

50 - 80 mg per kg of body weight

Dosage regimen

From 50 To 80 mg per kg of body weight once every day for 14 day(s)

Detailed description

50–80 mg/kg once daily for 14-21 days. The recommended treatment durations vary and national or local guidelines should be taken into consideration.

Dosage considerations

Ceftriaxone can be administered by intravenous infusion over at least 30 minutes (preferred route) or by slow intravenous injection over 5 minutes. Intravenous intermittent injection should be given over 5 minutes preferably in larger veins.

50-80 mg/kg once daily

Route of admnistration

Intramuscular

Defined daily dose

50 - 80 mg per kg of body weight

Dosage regimen

From 50 To 80 mg per kg of body weight once every day for 14 day(s)

Detailed description

50–80 mg/kg once daily for 14-21 days. The recommended treatment durations vary and national or local guidelines should be taken into consideration.

Dosage considerations

Intramuscular injections should be injected well within the bulk of a relatively large muscle and not more than 1 g should be injected at one site. Dosages greater than 1 g should be divided and injected at more than one site.

Active ingredient

Ceftriaxone

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.

Read more about Ceftriaxone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.